Archived News |

November 9, 2007

COP pharmacy awarded $150,000 to research brain cancer

The Children's Brain Tumor Foundation funds only three research projects each year. This year, one of those funded projects is from the University of Louisiana at Monroe College of Pharmacy.

Karen Briski, Ph.D. and department head of basic pharmaceutical sciences, was awarded a $150,000 grant for the project, 鈥淣ovel Delivery Modes for Small Molecule Inhibitors of Medulloblastoma." She will attend a special reception in New York City on Nov. 13 to accept the award.

Medulloblastoma is the most common pediatric brain tumor for which no satisfactory treatments currently exist, Briski said.

鈥淒ue to the severe, long-term side effects of radiation and chemotherapy, new non-toxic, molecular-based approaches are urgently needed," said Briski. 鈥淭hrough this project, I believe we can make an important contribution to a significant problem.鈥�

Briski's interdisciplinary research team has collective expertise in pharmaceutics, neuroscience, nanotechnology, X-ray fluorescence spectrometry, and toxicology. 鈥淚 am always looking for the College of Pharmacy to engage in projects that enable the usage of interdisciplinary research. I believe major breakthroughs occur when a team-based approach is used," she said.

Her team includes:

• Seetharama Jois, Amal Kaddoumi, Kevin Baer鈥攁ll Ph.D.s from 不良研究所's College of Pharmacy
  
  
• Gary Glass of the University of Louisiana at Lafayette's Louisiana Accelerator Center
  
  
• Amitava Roy and Challa Kumar of Louisiana State University's Center for Microstructures and Devices in Baton Rouge.

The researchers will pursue the following objectives:

• develop novel pharmaceutical mechanisms for optimal delivery of agents targeting the molecular pathogenesis of medulloblastoma
  
  
• correlate drug accumulation with medulloblastoma tumor cell death and tumor regression
  
  
• evaluate non-specific uptake and potential adverse effects of drug treatment on normal brain tissue and other organs.

For additional information about this project, contact Briski at briski@ulm.edu

PLEASE NOTE: Some links and e-mail addresses in these archived news stories may no longer work, and some content may include events which are no longer relevent, or reference individuals and/or organizations no longer associated with 不良研究所.